» Articles » PMID: 36389844

Bone Marrow Mesenchymal Stem Cells in Premature Ovarian Failure: Mechanisms and Prospects

Overview
Journal Front Immunol
Date 2022 Nov 17
PMID 36389844
Authors
Affiliations
Soon will be listed here.
Abstract

Premature ovarian failure (POF) is a common female reproductive disorder and characterized by menopause, increased gonadotropin levels and estrogen deficiency before the age of 40 years old. The etiologies and pathogenesis of POF are not fully clear. At present, hormone replacement therapy (HRT) is the main treatment options for POF. It helps to ameliorate perimenopausal symptoms and related health risks, but can't restore ovarian function and fertility fundamentally. With the development of regenerative medicine, bone marrow mesenchymal stem cells (BMSCs) have shown great potential for the recovery of ovarian function and fertility based on the advantages of abundant sources, high capacity for self-renewal and differentiation, low immunogenicity and less ethical considerations. This systematic review aims to summarize the possible therapeutic mechanisms of BMSCs for POF. A detailed search strategy of preclinical studies and clinical trials on BMSCs and POF was performed on PubMed, MEDLINE, Web of Science and Embase database. A total of 21 studies were included in this review. Although the standardization of BMSCs need more explorations, there is no doubt that BMSCs transplantation may represent a prospective therapy for POF. It is hope to provide a theoretical basis for further research and treatment for POF.

Citing Articles

Human hair follicle-derived mesenchymal stem cells improve ovarian function in cyclophosphamide-induced POF mice.

Mo J, Hu H, Li P, Ye Y, Chen W, Chen L Stem Cell Res Ther. 2025; 16(1):67.

PMID: 39934888 PMC: 11816600. DOI: 10.1186/s13287-024-04097-1.


Investigation on the molecular mechanism of SPA interference with osteogenic differentiation of bone marrow mesenchymal stem cells.

Wen H, Zhu S, Yang H, Guo F Sci Rep. 2024; 14(1):15600.

PMID: 38971916 PMC: 11227578. DOI: 10.1038/s41598-024-66502-2.


Mesenchymal stem cells promote ovarian reconstruction in mice.

Li J, Fan H, Liu W, Zhang J, Xiao Y, Peng Y Stem Cell Res Ther. 2024; 15(1):115.

PMID: 38650029 PMC: 11036642. DOI: 10.1186/s13287-024-03718-z.


Application of mesenchymal stem cell therapy for premature ovarian insufficiency: Recent advances from mechanisms to therapeutics.

Hu H, Xin X, Zhu Y, Fan R, Zhang H, Ye Y World J Stem Cells. 2024; 16(1):1-6.

PMID: 38292439 PMC: 10824040. DOI: 10.4252/wjsc.v16.i1.1.


Protective role of stem cells in POI: Current status and mechanism of action, a review article.

Sadeghi S, Mosaffa N, Huang B, Ramezani Tehrani F Heliyon. 2024; 10(1):e23271.

PMID: 38169739 PMC: 10758796. DOI: 10.1016/j.heliyon.2023.e23271.


References
1.
Luz-Crawford P, Kurte M, Bravo-Alegria J, Contreras R, Nova-Lamperti E, Tejedor G . Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther. 2013; 4(3):65. PMC: 3706898. DOI: 10.1186/scrt216. View

2.
Forsberg M, Kink J, Hematti P, Capitini C . Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol. 2020; 8:665. PMC: 7379234. DOI: 10.3389/fcell.2020.00665. View

3.
Meng Z, Feng G, Hu X, Yang L, Yang X, Jin Q . SDF Factor-1α Promotes the Migration, Proliferation, and Osteogenic Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells Through the Wnt/β-Catenin Pathway. Stem Cells Dev. 2020; 30(2):106-117. DOI: 10.1089/scd.2020.0165. View

4.
Bao R, Xu P, Wang Y, Wang J, Xiao L, Li G . Bone marrow derived mesenchymal stem cells transplantation rescues premature ovarian insufficiency induced by chemotherapy. Gynecol Endocrinol. 2017; 34(4):320-326. DOI: 10.1080/09513590.2017.1393661. View

5.
Chen X, Wang Q, Li X, Wang Q, Xie J, Fu X . Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure. Stem Cell Res Ther. 2018; 9(1):240. PMC: 6158904. DOI: 10.1186/s13287-018-0964-4. View